Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.890
-0.030 (-1.56%)
At close: Feb 20, 2026, 4:00 PM EST
1.920
+0.030 (1.59%)
After-hours: Feb 20, 2026, 7:27 PM EST
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $50.21M in the quarter ending September 30, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to $218.88M, up 7.90% year-over-year. In the year 2024, Treace Medical Concepts had annual revenue of $209.36M with 11.89% growth.
Revenue (ttm)
$218.88M
Revenue Growth
+7.90%
P/S Ratio
0.55
Revenue / Employee
$458,866
Employees
477
Market Cap
120.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 209.36M | 22.24M | 11.89% |
| Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
| Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
| Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
| Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
| Dec 31, 2019 | 39.42M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 347.03M |
| InfuSystem Holdings | 141.05M |
| Neuronetics | 129.87M |
| AVITA Medical | 71.61M |
| LENSAR | 59.14M |
| CVRx, Inc. | 56.65M |
| Apyx Medical | 47.90M |
| Nano-X Imaging | 12.30M |
TMCI News
- 3 days ago - First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review - Seeking Alpha
- 10 days ago - Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - GlobeNewsWire
- 5 weeks ago - Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - GlobeNewsWire
- 6 weeks ago - Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - GlobeNewsWire
- 2 months ago - Treace Medical Secures Up to $175 Million in Debt Financing - GlobeNewsWire
- 3 months ago - Treace Medical Concepts, Inc. (TMCI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Treace Announces Participation in Two Upcoming Investor Conferences - GlobeNewsWire